0001140361-15-015661.txt : 20150417 0001140361-15-015661.hdr.sgml : 20150417 20150417081141 ACCESSION NUMBER: 0001140361-15-015661 CONFORMED SUBMISSION TYPE: 15-12B PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20150417 DATE AS OF CHANGE: 20150417 EFFECTIVENESS DATE: 20150417 FILER: COMPANY DATA: COMPANY CONFORMED NAME: UROPLASTY INC CENTRAL INDEX KEY: 0000890846 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 411719250 STATE OF INCORPORATION: MN FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 15-12B SEC ACT: 1934 Act SEC FILE NUMBER: 001-32632 FILM NUMBER: 15776554 BUSINESS ADDRESS: STREET 1: 5420 FELTL ROAD CITY: MINNETONKA STATE: MN ZIP: 55343 BUSINESS PHONE: (952) 426-6140 MAIL ADDRESS: STREET 1: 5420 FELTL ROAD CITY: MINNETONKA STATE: MN ZIP: 55343 15-12B 1 form1512b.htm UROPLASTY, INC 15-12B 4-17-2015
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 15

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number:  001-32632

UROPLASTY, INC.
(Exact name of registrant as specified in its charter)

5420 Feltl Road
Minnetonka, Minnesota 55343
(952) 426-6140
(Address, including zip code, and telephone number, including area code,
of registrant’s principal executive offices)

Common Stock, par value $0.01 per share
(Title of each class of securities covered by this Form)

None
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

Rule 12g-4(a)(1) ☒
Rule 12g-4(a)(2) ☐
Rule 12h-3(b)(1)(i) ☒
Rule 12h-3(b)(1)(ii) ☐
Rule 15d-6 ☐

Approximate number of holders of record as of the certification or notice date: zero (0).

Explanatory Note:  By virtue of the merger of Uroplasty, Inc. (“Uroplasty”) with and into Uroplasty LLC (formerly known as Visor Merger Sub LLC), the sole member of which is Cogentix Medical, Inc. (formerly known as Vision-Sciences, Inc.), Cogentix Medical, Inc. has assumed Uroplasty’s reporting obligations under Section 15(d) of the Securities Exchange Act of 1934, as amended.

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, Uroplasty, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

Date: April 17, 2015
By:
/s/ Brett A. Reynolds
 
Brett A. Reynolds
 
Senior Vice President, Chief Financial Officer and
 
Corporate Secretary
 
OPPENHEIMER: 2742795 v01 10/26/2009